slow in Biological Technology
Navigation Links
slow in Biological Technology
AKRON, Ohio, Dec. 12 /PRNewswire/ -- An Ohio-based company has
successfully grown the first Low Radiocarb(TM) food, in this case soybeans,
with significantly lower levels of harmful radioactive carbon-14 than normally
found in food. Infants and children nourished with safer, low radiocarbon
LifeBl...
Ads Creatively Depict the Predictable Relief Provided by the Only Commercially Available Prescription Treatment for Chronic Idiopathic Constipation in Adults DEERFIELD, Ill., Nov. 6 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. and Sucampo Pharmaceutica...
...t to wider adoption of assay technology to safeguard waterways from invasive harmful algae blooms. The high cost, complicated sample preparation, and slow pace of legacy monitoring systems have been impediments to achieving reliable results in the early detection of harmful algae blooms," said Tom Hurfor...
... the total amount of AB. As EVP-0962 does not affect other gamma secretase substrates required for normal function, such as Notch, it is predicted to slow the progression of Alzheimer's disease by reducing the disease-associated toxic AB42 species and to display an intrinsically superior safety profile c...
...ars (DALYs), along with the impact of interventions that can reduce risk or slow progression. Projecting the future burden of AD is important for researche...ating the potential impact of interventions that may reduce disease risk or slow disease progression. "This kind of work is important and we app...
... of his disease. Reeder's physicians began treating him with Nexavar , an oral multiple kinase inhibitor that has been shown to significantly slow the spread of advanced kidney cancer in a majority of patients. By filling his prescription through OncologyRx Care Advantage, Reeder was eligible to ...
...al, 81.3% and 63.6% of patients achieving viral negativity at Week 12 went on to have an SVR in the 9 mcg and 15 mcg arms, respectively. In addition, slow responders achieved SVR rates of 11.7% and 35.4% in the 9 mcg and 15 mcg arms. Regardless of treatment dose used, attaining viral negativity at Week ...
...tment by reducing appetite, increasing metabolism and allowing the body to continue losing weight by offsetting its natural tendency to fight back and slow down the weight loss process. About Orexigen(R) Therapeutics Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the tr...
...nefit was observed in either study for these functions, possibly due to the slow progression of the disease. RP patients in general have a gradual progressi...vestigator for the RP studies. "However, the progression of this disease is slow and we have not seen a visual benefit in the treated eye relative to the co...
...es or delays in the development, testing, regulatory approvals for trial commencement, progression or production of Cytokinetics' compounds that could slow or prevent clinical development or product approval, and including risks that current and past results of clinical trials or preclinical studies may n...
...g, unexpected adverse side effects or inadequate therapeutic efficacy of the Company's drug compounds, including, but not limited to, PBT2, that could slow or prevent products coming to market, the uncertainty of patent protection for the Company's intellectual property or trade secrets, including, but no...
... and only half of the patients who are diagnosed receive treatment that can slow the progression of AD symptoms. Alzheimer's disease gradually destroy...hile there is no cure for Alzheimer's disease, there are treatments to help slow the progression of the symptoms of the disease. About Eisai Corporati...
... non-profit biotech. About ALS TDI The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI exe...
...ng systems, but also to the development of synthetic vaccines to prevent or slow future epidemics. A synthetic H1N1 Replikins Vaccine is available for ...ng systems, but also to the development of synthetic vaccines to prevent or slow future epidemics. The original release can be found at http://www.m...
...& DHA. Each of these compounds has shown effectiveness in scientific studies as nutrients with powerful antioxidant properties and the ability to slow and or prevent tumor growth. Now researchers are finding that the effectiveness of these nutrients is further enhanced when taken together, demonstra...
...fornia, San Diego . Dr. Salvesen's research focuses on the central role enzyme pathways play in the life and death of cells. When death pathways slow down in cells that are normally programmed to die, cancer results. Conversely, when death pathways become overactive in cells that are programmed to ...
...nts as participants in clinical research studies. Throughout the world, the single most costly delay in bringing new treatments to market is the slow enrollment of clinical trials, with each day a trial doesn't enroll potentially equivalent to millions of dollars in lost revenue due to treatment pat...
...I-007 significantly and dose-dependently increased slow wave sleep and decreased the duration of wake afte...mprovements such as increased total sleep time and slow wave sleep are associated with reports of improved...th ITI-007 experienced dose-dependent increases in slow wave sleep (SWS) and dramatic decreases in wake af...
Ads Creatively Depict the Predictable Relief Provided by the Only Commercially Available Prescription Treatment for Chronic Idiopathic Constipation in Adults DEERFIELD, Ill., Nov. 6 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. and Sucampo Pharmaceutica...
Hot products launch in summer's slow days
Never mind about the dog days of summer slowing the flow of news in the technology business. On Monday, both Macromedia and Fujitsu made significant product announcements. Macromedia announced the much-anticipated Macromedia Studio 8, its development suite for web developers and designers, alo...Stem-cell controversies slow progress
While the University of Wisconsin-Madison continues to make stem-cell advances , such as the two proof-of-concept cell cultures announced over the weekend, things aren't going so well elsewhere in the world: Korean scandal Hwang Woo-suk, a South Korean stem-cell researcher, fell from grace...Healthcare slow to adopt genetic advances
Milwaukee, Wis - Understanding our genetic makeup and predicting our predisposition to disease has advanced to the point where DNA testing services, including online versions, are available to consumers interested in shaping their own health management. Patients, however, will have to exercise pa...Businesses are slow to adopt Web 2.0 concepts
Madison, Wis. - The notion of improving business processes with enterprise-centric Internet tools is hardly new, but one local expert believes the relatively slow pace of adoption means that reluctant business leaders need an education in Web 2.0. Their need for a tutorial can hardly be attrib...PDI Reports 2009 Second Quarter Financial Results
...es Services segment, two of which are prior PDI customers and two of which are new. These additional client engagements, coming during what has been a slow period in the industry, and given the strategic shift in how big pharmaceutical companies are approaching outsourced sales, speaks positively about th...GeoVax Labs, Inc. Provides Clinical Studies Update
...otective antibody response against the natural form of the virus envelope glycoprotein as well as protective T cells. "Vaccine trials can be a slow process," said Harriet Robinson, Ph.D., developer of the vaccine and Senior V.P. of Research and Development. "The therapeutic trials should move more...ERT Reports Second Quarter 2009 Results
...ult economic environment and uncertainty in pharmaceutical sponsors' spending, especially Thorough QT trials. However, despite what is historically a slow summer period, we are seeing higher levels of new business development activity. We believe the fundamentals of our industry remain strong and that w......t to wider adoption of assay technology to safeguard waterways from invasive harmful algae blooms. The high cost, complicated sample preparation, and slow pace of legacy monitoring systems have been impediments to achieving reliable results in the early detection of harmful algae blooms," said Tom Hurfor...
Looking Older Than You Are May Have Little to Do With Wrinkles
...nd prevention. The worse it gets, the worse it gets, is how she phrased the dilemma. "By correcting early with smaller volume treatments, you can slow the aging process and allay the need for major procedures later on. It really is a 'worse begets worse' scenario because once the skin begins to lose ...... the total amount of AB. As EVP-0962 does not affect other gamma secretase substrates required for normal function, such as Notch, it is predicted to slow the progression of Alzheimer's disease by reducing the disease-associated toxic AB42 species and to display an intrinsically superior safety profile c...
...ars (DALYs), along with the impact of interventions that can reduce risk or slow progression. Projecting the future burden of AD is important for researche...ating the potential impact of interventions that may reduce disease risk or slow disease progression. "This kind of work is important and we app...
New drugs faster from natural compounds: A UC San Diego breakthrough
...cally important biological compounds that remain virtually untouched by computational research. As a result, it is currently one of the most painfully slow processes, it is a real bottleneck that we have now removed," said Pavel Pevzner, a computer science professor at UC San Diego's Jacobs School of Engi...Novel drug discovery tool could identify promising new therapies for Parkinson's disease
...tiveness in later stages of the disease, and there is currently no means to slow the disease's progressive course. In most cases, the cause of Parkinson'...upporting clinical trials in patients to test whether specific antioxidants slow the progression of Parkinson's disease. High doses of heavy metals such as ...... of his disease. Reeder's physicians began treating him with Nexavar , an oral multiple kinase inhibitor that has been shown to significantly slow the spread of advanced kidney cancer in a majority of patients. By filling his prescription through OncologyRx Care Advantage, Reeder was eligible to ...
Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
...up to six-high. Targeted containers must then be moved to an inspection facility where their contents are scanned using sensitive equipment. This is a slow process that involves sophisticated tools and specialized training that only support limited throughput. Consequently, there would be major delays ass...Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
...; www.mlb.com/4als About ALS TDI The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI ex...Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes
... drugs to market, time and predictability throughout the R&D process are essential. Even in the early pre-clinical phase, any unpredictability may slow the testing of early investigational compounds by causing scheduling delays that cost the manufacturer lost time and money. In many cases, freshly is......al, 81.3% and 63.6% of patients achieving viral negativity at Week 12 went on to have an SVR in the 9 mcg and 15 mcg arms, respectively. In addition, slow responders achieved SVR rates of 11.7% and 35.4% in the 9 mcg and 15 mcg arms. Regardless of treatment dose used, attaining viral negativity at Week ...
...tment by reducing appetite, increasing metabolism and allowing the body to continue losing weight by offsetting its natural tendency to fight back and slow down the weight loss process. About Orexigen(R) Therapeutics Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the tr...
Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus
...chment in the nasal membrane. This gives a mechanical barrier to protect the person until their own immune system can build-up protection. This should slow the frequency of the virus in the environment." Dr. Nash continued, "When blockage of the attachment of the virus is the objective, the immunoglo......nefit was observed in either study for these functions, possibly due to the slow progression of the disease. RP patients in general have a gradual progressi...vestigator for the RP studies. "However, the progression of this disease is slow and we have not seen a visual benefit in the treated eye relative to the co...
Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate
... as first-line medical personnel," said Sean Tucker, Ph.D., Vaxart vice president of research. Currently, pandemic flu vaccines are prepared by a slow and inefficient process that requires about six months before the first large amounts of vaccine are available. This process depends on creating an en......es or delays in the development, testing, regulatory approvals for trial commencement, progression or production of Cytokinetics' compounds that could slow or prevent clinical development or product approval, and including risks that current and past results of clinical trials or preclinical studies may n...
Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States
... visit www.mlb.com . About ALS TDI The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI ex......g, unexpected adverse side effects or inadequate therapeutic efficacy of the Company's drug compounds, including, but not limited to, PBT2, that could slow or prevent products coming to market, the uncertainty of patent protection for the Company's intellectual property or trade secrets, including, but no...
BioMS Medical Announces First quarter 2009 results
...e, President and CEO of BioMS Medical. "We have demonstrated in previous trials that dirucotide has shown to be well tolerated and has the capacity to slow the progression of disease in certain genetically pre-disposed MS patients. If our pivotal trials confirm these results, we believe dirucotide could r...American Oriental Bioengineering Reports First Quarter 2009 Financial Results
... 2009 and December 31, 2008, respectively 31,812,778 36,982,167 Inventories, net of provision for slow moving inventories 17,954,075 13,042,123 Advances to suppliers 2,241,176 3,593,979 Notes ...... and only half of the patients who are diagnosed receive treatment that can slow the progression of AD symptoms. Alzheimer's disease gradually destroy...hile there is no cure for Alzheimer's disease, there are treatments to help slow the progression of the symptoms of the disease. About Eisai Corporati...
... non-profit biotech. About ALS TDI The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI exe...
...ng systems, but also to the development of synthetic vaccines to prevent or slow future epidemics. A synthetic H1N1 Replikins Vaccine is available for ...ng systems, but also to the development of synthetic vaccines to prevent or slow future epidemics. The original release can be found at http://www.m...
Biotechnology Company Provided Advance Warning of Mexican H1N1 "Swine Flu" Virus Outbreak
...he development of synthetic vaccines to prevent or slow future epidemics. A synthetic H1N1 Replikins Vacci...he development of synthetic vaccines to prevent or slow future epidemics. Replikins, Ltd. published a...he development of synthetic vaccines to prevent or slow future epidemics. The original release can be ......& DHA. Each of these compounds has shown effectiveness in scientific studies as nutrients with powerful antioxidant properties and the ability to slow and or prevent tumor growth. Now researchers are finding that the effectiveness of these nutrients is further enhanced when taken together, demonstra...
Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.
...g, unexpected adverse side effects or inadequate therapeutic efficacy of the Company's drug compounds, including, but not limited to, PBT2, that could slow or prevent products coming to market, the uncertainty of patent protection for the Company's intellectual property or trade secrets, including, but no...Fitter frames: Nanotubes boost structural integrity of composites
...ed mobility enables the epoxy to craze or result in the formation of a network of pillar-like fibers that bridge together both sides of the crack and slow its growth. "This crazing behavior, and the bridging fibers it produces, dramatically slows the growth rate of a crack," Koratkar said. "In order f......fornia, San Diego . Dr. Salvesen's research focuses on the central role enzyme pathways play in the life and death of cells. When death pathways slow down in cells that are normally programmed to die, cancer results. Conversely, when death pathways become overactive in cells that are programmed to ...
...nts as participants in clinical research studies. Throughout the world, the single most costly delay in bringing new treatments to market is the slow enrollment of clinical trials, with each day a trial doesn't enroll potentially equivalent to millions of dollars in lost revenue due to treatment pat...
BioMS Medical Announces 2008 Year End Results
...aid Kevin Giese, President and CEO of BioMS Medical. "Our hope is that the results of this trial will confirm that dirucotide is able to significantly slow the progression of MS, specifically in patients with secondary progressive multiple sclerosis." Currently, BioMS is conducting two clinical trials a......I-007 significantly and dose-dependently increased slow wave sleep and decreased the duration of wake afte...mprovements such as increased total sleep time and slow wave sleep are associated with reports of improved...th ITI-007 experienced dose-dependent increases in slow wave sleep (SWS) and dramatic decreases in wake af...
Other Tagsneurodegenerativemattersmattersmonthmonthmonththisthisthiscontributesdisableawarded
neurodegenerativeprosthesesobjectsmatterscoyotesmonththisdefeaturaniumretinoiccontributesdisableawardedTGen
Breaking Biology News(10 mins):ADA releases updated position paper on nutrient supplementation 2MSU researcher unveils new approach to treat lower back pain 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4Triage Wireless Inc Becomes Sotera Wireless Inc 6282 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lilly Surpasses United Way 2009 Campaign Goal 6272 1Lilly Surpasses United Way 2009 Campaign Goal 6272 2Lilly Surpasses United Way 2009 Campaign Goal 6272 3
Breaking Medicine News(10 mins):Health News:Allegheny Medical Achieves Remarkable Success with Their Fibromyalgia Flow Care Plan 2Health News:Allegheny Medical Achieves Remarkable Success with Their Fibromyalgia Flow Care Plan 3Health News:World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins 2Health News:World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins 3Health News:Study highlights implications of influenza pandemics on blood supplies 2Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 3Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 4
Other Contentsplaqueplaqueplaqueplaqueplaqueplaqueplaqueplaqueplastidplateauplateauplateauplateletsplateletsplateletsplateletsplateletspleiotropypleurapleura[0] Allegheny Medical Achieves Remarkable Success with Their Fibromyalgia Flow Care Plan [0] World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins[0] Study highlights implications of influenza pandemics on blood supplies[1] Lung Cancer Alliance Praises Growing National Coalition[1] AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |